What is Vikand?
VIKAND Medical Solutions distinguishes itself as the premier provider of comprehensive medical solutions tailored for the maritime sector, including cruise lines, yachts, and offshore operations. Managed by a world-class medical team, VIKAND leverages extensive experience in both medicine and the marine industry to offer a 24/7 on-call service. The company is recognized for its ability to customize services to meet the direct needs of cruise operators, providing concierge-level solutions. VIKAND addresses the fragmentation often associated with maritime medical needs by consolidating services, thereby simplifying complex requirements. Their technological offerings include the innovative Hygensea Odorox® solution, an advanced system for air purification and surface decontamination that mimics natural atmospheric cleaning processes, utilizing a patented, FDA-approved technology to eliminate odors, viruses, and bacteria.
How much funding has Vikand raised?
Vikand has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Vikand?
With the recent influx of capital from a large-scale, late-stage funding round, Vikand is strategically positioned for significant expansion and enhancement of its service offerings. The substantial investment, characterized as a major strategic backing, suggests a focus on scaling operations, potentially broadening its technological solutions like the Hygensea Odorox®, and further solidifying its market leadership. This financing will likely enable Vikand to deepen its penetration in the cruise, yachting, and offshore markets, possibly through new partnerships, service area expansions, or advancements in its medical and technological capabilities. The company's trajectory indicates a strong emphasis on innovation and operational excellence to meet the evolving health and safety demands of the maritime industry.
See full Vikand company page
